Literature DB >> 24295976

Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa.

Gabriel Navarro1, Andrew T Cheng, Kelly C Peach, Walter M Bray, Valerie S Bernan, Fitnat H Yildiz, Roger G Linington.   

Abstract

To date, most antibiotics have primarily been developed to target bacteria in the planktonic state. However, biofilm formation allows bacteria to develop tolerance to antibiotics and provides a mechanism to evade innate immune systems. Therefore, there is a significant need to identify small molecules to prevent biofilm formation and, more importantly, to disperse or eradicate preattached biofilms, which are a major source of bacterial persistence in nosocomial infections. We now present a modular high-throughput 384-well image-based screening platform to identify Pseudomonas aeruginosa biofilm inhibitors and dispersal agents. Biofilm coverage measurements were accomplished using non-z-stack epifluorescence microscopy to image a constitutively expressing green fluorescent protein (GFP)-tagged strain of P. aeruginosa and quantified using an automated image analysis script. Using the redox-sensitive dye XTT, bacterial cellular metabolic activity was measured in conjunction with biofilm coverage to differentiate between classical antibiotics and nonantibiotic biofilm inhibitors/dispersers. By measuring biofilm coverage and cellular activity, this screen identifies compounds that eradicate biofilms through mechanisms that are disparate from traditional antibiotic-mediated biofilm clearance. Screening of 312 natural-product prefractions identified the cyclic depsipeptide natural products skyllamycins B and C as nonantibiotic biofilm inhibitors with 50% effective concentrations (EC50s) of 30 and 60 μM, respectively. Codosing experiments of skyllamycin B and azithromycin, an antibiotic unable to clear preattached biofilms, demonstrated that, in combination, these compounds were able to eliminate surface-associated biofilms and depress cellular metabolic activity. The skyllamycins represent the first known class of cyclic depsipeptide biofilm inhibitors/dispersers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24295976      PMCID: PMC3910817          DOI: 10.1128/AAC.01781-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  High-content screening for biofilm assays.

Authors:  Fubing Peng; Eric M V Hoek; Robert Damoiseaux
Journal:  J Biomol Screen       Date:  2010-07-16

3.  Small molecule inhibitors of bacterial quorum sensing and biofilm formation.

Authors:  Grant D Geske; Rachel J Wezeman; Adam P Siegel; Helen E Blackwell
Journal:  J Am Chem Soc       Date:  2005-09-21       Impact factor: 15.419

4.  Aerosol polymyxin and pneumonia in seriously ill patients.

Authors:  T W Feeley; G C Du Moulin; J Hedley-Whyte; L S Bushnell; J P Gilbert; D S Feingold
Journal:  N Engl J Med       Date:  1975-09-04       Impact factor: 91.245

5.  "Function-first" lead discovery: mode of action profiling of natural product libraries using image-based screening.

Authors:  Christopher J Schulze; Walter M Bray; Marcos H Woerhmann; Joshua Stuart; R Scott Lokey; Roger G Linington
Journal:  Chem Biol       Date:  2013-02-21

Review 6.  Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.

Authors:  Marilee D Obritsch; Douglas N Fish; Robert MacLaren; Rose Jung
Journal:  Pharmacotherapy       Date:  2005-10       Impact factor: 4.705

7.  Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants.

Authors:  David A D'Argenio; M Worth Calfee; Paul B Rainey; Everett C Pesci
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

8.  Biosynthetic gene cluster of the non-ribosomally synthesized cyclodepsipeptide skyllamycin: deciphering unprecedented ways of unusual hydroxylation reactions.

Authors:  Stefan Pohle; Christian Appelt; Mallorie Roux; Hans-Peter Fiedler; Roderich D Süssmuth
Journal:  J Am Chem Soc       Date:  2011-04-01       Impact factor: 15.419

9.  Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics.

Authors:  Weng Ruh Wong; Allen G Oliver; Roger G Linington
Journal:  Chem Biol       Date:  2012-11-21

10.  Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

Authors:  J J Smith; S M Travis; E P Greenberg; M J Welsh
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

View more
  15 in total

1.  Integration of high-content screening and untargeted metabolomics for comprehensive functional annotation of natural product libraries.

Authors:  Kenji L Kurita; Emerson Glassey; Roger G Linington
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-14       Impact factor: 11.205

2.  Natural products as inspiration for the development of bacterial antibiofilm agents.

Authors:  Roberta J Melander; Akash K Basak; Christian Melander
Journal:  Nat Prod Rep       Date:  2020-07-01       Impact factor: 13.423

3.  Optimized quinoline amino alcohols as disruptors and dispersal agents of Vibrio cholerae biofilms.

Authors:  Brian León; F P Jake Haeckl; Roger G Linington
Journal:  Org Biomol Chem       Date:  2015-08-21       Impact factor: 3.876

Review 4.  Microtiter plate assays to assess antibiofilm activity against bacteria.

Authors:  Evan F Haney; Michael J Trimble; Robert E W Hancock
Journal:  Nat Protoc       Date:  2021-04-28       Impact factor: 13.491

Review 5.  Comparative mass spectrometry-based metabolomics strategies for the investigation of microbial secondary metabolites.

Authors:  Brett C Covington; John A McLean; Brian O Bachmann
Journal:  Nat Prod Rep       Date:  2017-01-04       Impact factor: 13.423

Review 6.  Living in the matrix: assembly and control of Vibrio cholerae biofilms.

Authors:  Jennifer K Teschler; David Zamorano-Sánchez; Andrew S Utada; Christopher J A Warner; Gerard C L Wong; Roger G Linington; Fitnat H Yildiz
Journal:  Nat Rev Microbiol       Date:  2015-05       Impact factor: 60.633

7.  Increased diversity of peptidic natural products revealed by modification-tolerant database search of mass spectra.

Authors:  Alexey Gurevich; Alla Mikheenko; Alexander Shlemov; Anton Korobeynikov; Hosein Mohimani; Pavel A Pevzner
Journal:  Nat Microbiol       Date:  2018-01-22       Impact factor: 17.745

8.  Current Research Approaches to Target Biofilm Infections.

Authors:  Erik van Tilburg Bernardes; Shawn Lewenza; Shauna Reckseidler-Zenteno
Journal:  Postdoc J       Date:  2015-06

9.  Development of benzo[1,4]oxazines as biofilm inhibitors and dispersal agents against Vibrio cholerae.

Authors:  Christopher J A Warner; Andrew T Cheng; Fitnat H Yildiz; Roger G Linington
Journal:  Chem Commun (Camb)       Date:  2015-01-25       Impact factor: 6.222

10.  Biofilm Formation and Detachment in Gram-Negative Pathogens Is Modulated by Select Bile Acids.

Authors:  Laura M Sanchez; Andrew T Cheng; Christopher J A Warner; Loni Townsley; Kelly C Peach; Gabriel Navarro; Nicholas J Shikuma; Walter M Bray; Romina M Riener; Fitnat H Yildiz; Roger G Linington
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.